ICU Medical Revenue 2011-2025 | ICUI
ICU Medical revenue from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
ICU Medical Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $2,382 |
| 2023 | $2,259 |
| 2022 | $2,280 |
| 2021 | $1,316 |
| 2020 | $1,271 |
| 2019 | $1,266 |
| 2018 | $1,400 |
| 2017 | $1,293 |
| 2016 | $379 |
| 2015 | $342 |
| 2014 | $309 |
| 2013 | $314 |
| 2012 | $317 |
| 2011 | $302 |
| 2010 | $283 |
|
ICU Medical Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $537 |
| 2025-06-30 | $549 |
| 2025-03-31 | $605 |
| 2024-12-31 | $630 |
| 2024-09-30 | $589 |
| 2024-06-30 | $596 |
| 2024-03-31 | $567 |
| 2023-12-31 | $588 |
| 2023-09-30 | $553 |
| 2023-06-30 | $549 |
| 2023-03-31 | $569 |
| 2022-12-31 | $578 |
| 2022-09-30 | $598 |
| 2022-06-30 | $561 |
| 2022-03-31 | $543 |
| 2021-12-31 | $341 |
| 2021-09-30 | $336 |
| 2021-06-30 | $322 |
| 2021-03-31 | $318 |
| 2020-12-31 | $320 |
| 2020-09-30 | $319 |
| 2020-06-30 | $303 |
| 2020-03-31 | $329 |
| 2019-12-31 | $316 |
| 2019-09-30 | $307 |
| 2019-06-30 | $312 |
| 2019-03-31 | $331 |
| 2018-12-31 | $340 |
| 2018-09-30 | $327 |
| 2018-06-30 | $360 |
| 2018-03-31 | $372 |
| 2017-12-31 | $370 |
| 2017-09-30 | $343 |
| 2017-06-30 | $332 |
| 2017-03-31 | $248 |
| 2016-12-31 | $96 |
| 2016-09-30 | $97 |
| 2016-06-30 | $97 |
| 2016-03-31 | $90 |
| 2015-12-31 | $90 |
| 2015-09-30 | $86 |
| 2015-06-30 | $84 |
| 2015-03-31 | $81 |
| 2014-12-31 | $80 |
| 2014-09-30 | $77 |
| 2014-06-30 | $79 |
| 2014-03-31 | $73 |
| 2013-12-31 | $78 |
| 2013-09-30 | $83 |
| 2013-06-30 | $79 |
| 2013-03-31 | $74 |
| 2012-12-31 | $83 |
| 2012-09-30 | $81 |
| 2012-06-30 | $77 |
| 2012-03-31 | $76 |
| 2011-12-31 | $76 |
| 2011-09-30 | $76 |
| 2011-06-30 | $78 |
| 2011-03-31 | $71 |
| 2010-12-31 | $74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.321B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.106B | 26.06 |
| EssilorLuxottica (ESLOY) | France | $168.548B | 0.00 |
| Boston Scientific (BSX) | United States | $150.853B | 34.49 |
| Stryker (SYK) | United States | $137.722B | 27.34 |
| Medtronic (MDT) | Ireland | $123.497B | 17.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.264B | 0.00 |
| Agilent Technologies (A) | United States | $40.971B | 26.52 |
| ResMed (RMD) | United States | $35.713B | 24.72 |
| GE HealthCare Technologies (GEHC) | United States | $32.173B | 15.39 |
| Koninklijke Philips (PHG) | Netherlands | $26.943B | 17.60 |
| Insulet (PODD) | United States | $23.075B | 71.62 |
| Terumo (TRUMY) | Japan | $22.623B | 25.47 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.567B | 10.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.901B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Baxter (BAX) | United States | $9.135B | 7.37 |
| Bio-Rad Laboratories (BIO) | United States | $8.202B | 29.49 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.481B | 10.61 |
| Haemonetics (HAE) | United States | $3.479B | 15.48 |
| Envista Holdings (NVST) | United States | $3.142B | 18.03 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.836B | 12.93 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| Perrigo (PRGO) | Ireland | $1.866B | 4.68 |
| Phibro Animal Health (PAHC) | United States | $1.826B | 18.24 |
| AtriCure (ATRC) | United States | $1.647B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.433B | 9.21 |
| Neogen (NEOG) | United States | $1.395B | 26.75 |
| Curaleaf Holdings (CURLF) | Canada | $1.345B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.291B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 18.29 |
| Green Thumb Industries (GTBIF) | United States | $1.186B | 52.00 |
| Tilray Brands (TLRY) | Canada | $1.157B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.156B | 343.00 |
| InMode (INMD) | Israel | $0.879B | 9.94 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.854B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| Omeros (OMER) | United States | $0.644B | 0.00 |
| Surmodics (SRDX) | United States | $0.612B | 0.00 |
| CeriBell (CBLL) | United States | $0.478B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.474B | 16.33 |
| Evolus (EOLS) | United States | $0.451B | 0.00 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| BillionToOne (BLLN) | $0.417B | 0.00 | |
| Cresco Labs (CRLBF) | United States | $0.319B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.297B | 50.60 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.280B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.260B | 0.00 |
| Quanterix (QTRX) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.244B | 143.33 |
| Viemed Healthcare (VMD) | United States | $0.239B | 19.06 |
| High Tide (HITI) | Canada | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.224B | 2.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.223B | 0.00 |
| Organigram Global (OGI) | Canada | $0.201B | 0.00 |
| Exagen (XGN) | United States | $0.192B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 15.52 |
| FitLife Brands (FTLF) | United States | $0.165B | 20.35 |
| OraSure Technologies (OSUR) | United States | $0.161B | 0.00 |
| Apyx Medical (APYX) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.146B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.133B | 0.00 |
| Biote (BTMD) | United States | $0.118B | 5.16 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 12.96 |
| Sharps Technology (STSS) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Nephros (NEPH) | United States | $0.058B | 41.77 |
| ImmuCell (ICCC) | United States | $0.044B | 18.89 |
| Jin Medical (ZJYL) | China | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.19 |
| Bonk (BNKK) | United States | $0.024B | 0.00 |
| Zynex (ZYXI) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Functional Brands (MEHA) | $0.003B | 0.00 | |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |